Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;102(4):917-921.
doi: 10.1016/j.kint.2022.08.001. Epub 2022 Aug 11.

Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection

Judit Cacho  1 , David Nicolás  2 , Marta Bodro  3 , Elena Cuadrado-Payán  1 , Verónica Torres-Jaramillo  1 , Ángela Gonzalez-Rojas  1 , Pedro Ventura-Aguiar  4 , Enrique Montagud-Marrahi  1 , Sabina Herrera  3 , Veronica Rico  2 , Frederic Cofàn  1 , Frederic Oppenheimer  1 , Ignacio Revuelta  5 , Fritz Diekmann  6 , David Cucchiari  7
Affiliations

Use of remdesivir in kidney transplant recipients with SARS-CoV-2 Omicron infection

Judit Cacho et al. Kidney Int. 2022 Oct.
No abstract available

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Time-to-event analysis (Kaplan-Meier) for patients receiving remdesivir as early administration (≤7 daysfrom symptoms' start, blue line) or for patients with late or null administration (red line). The upper panel shows results for all patients’ population, whereas the lower panel shows results only for hospitalized patients (including hospital at home).
See this image and copyright information in PMC

References

    1. Villanego F., Vigara L.A., Alonso M., et al. Trends in COVID-19 outcomes in kidney transplant recipients during the period of omicron variant predominance. Transplantation. 2022;106:e304–e305. - PMC - PubMed
    1. Gueguen J., Colosio C., Del Bello A., et al. Early administration of anti–SARS-CoV-2 monoclonal antibodies prevents severe COVID-19 in kidney transplant patients. Kidney Int Rep. 2022;7:1241–1247. - PMC - PubMed
    1. Cucchiari D., Egri N., Bodro M., et al. Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients. Am J Transplant. 2021;21:2727–2739. - PMC - PubMed
    1. Beigel J.H., Tomashek K.M., Dodd L.E., et al. Remdesivir for the treatment of Covid-19—final report. N Engl J Med. 2020;383:1813–1826. - PMC - PubMed
    1. Gottlieb R.L., Vaca C.E., Paredes R., et al. Early remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med. 2022;386:305–315. - PMC - PubMed

MeSH terms